What is B. Riley’s Estimate for Celsius Q3 Earnings?

Celsius Holdings Inc. (NASDAQ:CELH) – Research analysts at B. Riley cut their Q3 2025 EPS estimates for shares of Celsius in a research report issued to clients and investors on Tuesday, July 29th. B. Riley analyst J. Van. Sinderen now forecasts that the company will post earnings per share of $0.22 for the quarter, down from their prior forecast of $0.23. B. Riley has a “Buy” rating and a $52.00 price target on the stock. The consensus estimate for Celsius’ current full-year earnings is $0.89 per share.

Celsius (NASDAQ:CELH) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.18 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.02). Celsius had a return on equity of 42.12% and a net margin of 8.40%. The company had revenue of $329.28 million during the quarter, compared to analysts’ expectations of $349.09 million. During the same period in the prior year, the business posted $0.27 EPS. The company’s quarterly revenue was down 7.4% on a year-over-year basis.

CELH has been the topic of several other research reports. JPMorgan Chase & Co. boosted their price target on Celsius from $39.00 to $44.00 and gave the company an “overweight” rating in a research note on Friday, May 2nd. Truist Financial lifted their target price on Celsius from $50.00 to $55.00 and gave the stock a “buy” rating in a report on Monday, July 14th. Citigroup began coverage on shares of Celsius in a report on Wednesday, July 23rd. They issued a “buy” rating and a $55.00 price target on the stock. Wall Street Zen upgraded shares of Celsius from a “sell” rating to a “hold” rating in a research note on Sunday, July 13th. Finally, Piper Sandler raised their target price on shares of Celsius from $44.00 to $45.00 and gave the stock an “overweight” rating in a report on Wednesday, June 4th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $47.28.

Celsius Price Performance

NASDAQ CELH opened at $46.54 on Wednesday. The company has a market cap of $12.00 billion, a price-to-earnings ratio of 145.44, a PEG ratio of 1.68 and a beta of 1.45. The stock’s fifty day moving average price is $43.13 and its 200 day moving average price is $35.14. Celsius has a 1 year low of $21.10 and a 1 year high of $48.47.

Institutional Trading of Celsius

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Alliancebernstein L.P. lifted its stake in Celsius by 26.3% in the 1st quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock valued at $642,769,000 after buying an additional 3,753,055 shares in the last quarter. Vanguard Group Inc. increased its stake in Celsius by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 15,813,110 shares of the company’s stock worth $416,517,000 after buying an additional 345,837 shares in the last quarter. Alyeska Investment Group L.P. raised its holdings in shares of Celsius by 60.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company’s stock valued at $181,164,000 after acquiring an additional 2,591,345 shares during the last quarter. FMR LLC lifted its position in shares of Celsius by 64.2% in the fourth quarter. FMR LLC now owns 4,055,148 shares of the company’s stock valued at $106,813,000 after acquiring an additional 1,585,839 shares in the last quarter. Finally, Champlain Investment Partners LLC acquired a new stake in shares of Celsius in the fourth quarter worth approximately $85,068,000. Hedge funds and other institutional investors own 60.95% of the company’s stock.

Insider Activity

In related news, CEO John Fieldly sold 130,803 shares of the business’s stock in a transaction on Tuesday, June 24th. The shares were sold at an average price of $45.00, for a total value of $5,886,135.00. Following the completion of the sale, the chief executive officer owned 1,038,577 shares of the company’s stock, valued at approximately $46,735,965. The trade was a 11.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Deborah Desantis sold 100,000 shares of the company’s stock in a transaction on Monday, July 28th. The stock was sold at an average price of $47.00, for a total transaction of $4,700,000.00. Following the transaction, the insider owned 17,917,770 shares of the company’s stock, valued at $842,135,190. This represents a 0.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 762,974 shares of company stock worth $35,158,418 over the last three months. 2.55% of the stock is currently owned by corporate insiders.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.